5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $4M | -$13M | 59.8% | -324.3% | -249.1% | -116.7% | -$11M | — | $4M |
| 2024 | $3M | -$14M | 52.2% | -420.1% | -229.0% | -138.9% | -$10M | — | $7M |
| 2023 | $3M | -$16M | 42.4% | -537.1% | -2002.7% | -245.6% | -$13M | — | $2M |
| 2022 | $691000 | -$19M | -92.8% | -2709.8% | -302.6% | -170.6% | -$13M | — | $2M |
| 2021 | $160000 | -$7M | 65.6% | -4038.1% | 34.3% | -76.0% | -$4M | — | $3M |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $1M | -$4M | 63.6% | -262.2% | 232.4% | -40.8% | -$3M | — | $2M |
| Mar '26 | $1M | -$3M | 68.5% | -237.9% | -183.4% | -27.1% | -$3M | — | $5M |
| Dec '25 | $1M | -$3M | 68.7% | -193.5% | -56.2% | -26.3% | -$2M | — | $4M |
| Sep '25 | $1M | -$3M | 65.9% | -289.2% | -69.6% | -32.2% | -$4M | — | $3M |
| Jun '25 | $564000 | -$3M | 43.4% | -506.6% | -41.2% | -24.9% | — | — | $8M |
| Mar '25 | $726000 | -$4M | 44.5% | -506.5% | -38.6% | -27.0% | — | — | $10M |
| Dec '24 | $770000 | -$3M | 45.8% | -412.1% | -51.7% | -31.4% | -$3M | — | $7M |
| Sep '24 | $887000 | -$3M | 47.1% | -362.5% | -38.9% | -24.4% | -$2M | — | $9M |
| Jun '24 | $901000 | -$4M | 52.2% | -429.7% | -459.9% | -63.7% | -$2M | — | $2M |
| Mar '24 | $719000 | -$4M | 65.4% | -487.6% | -98.7% | -44.6% | -$2M | — | $4M |
| Dec '23 | $808000 | -$3M | 69.2% | -388.7% | -402.8% | -49.4% | -$2M | — | $2M |
| Sep '23 | $944000 | -$3M | 56.7% | -357.8% | -132.4% | -45.5% | -$3M | — | $3M |
| Jun '23 | $743000 | -$4M | 26.1% | -581.7% | -474.5% | -43.5% | -$3M | — | $6M |
| Mar '23 | $433000 | -$5M | -10.9% | -1128.4% | -195.2% | -63.3% | -$4M | — | $3M |
| Dec '22 | $277000 | -$8M | -74.7% | -2862.1% | -126.4% | -71.3% | -$4M | — | $2M |
| Sep '22 | $208000 | -$3M | -45.2% | -1568.3% | -24.5% | -21.2% | -$3M | — | $3M |
| Jun '22 | $135000 | -$5M | -100.7% | -4041.5% | -36.3% | -30.3% | -$3M | — | $8M |
| Mar '22 | $71000 | -$2M | -287.3% | -2928.2% | 10.3% | -32.9% | -$3M | — | $5M |
| Dec '21 | $53000 | -$3M | 67.9% | -4834.0% | 13.8% | -30.7% | -$2M | — | $3M |
| Sep '21 | $70000 | -$2M | 74.3% | -2995.7% | 39.5% | — | -$1M | — | — |
How the market has priced TNON against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 4 years, Tenon Medical, Inc.'s revenue has grown 122.8% per year. These are computed facts, not advice.
As of FY2025, Tenon Medical, Inc. reported — of total debt against $4M of cash.
In FY2025, gross margin was 59.8%, operating margin -324.3%, and net margin -318.4%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.